Open Access System for Information Sharing

Login Library

 

Article
Cited 4 time in webofscience Cited 3 time in scopus
Metadata Downloads

The Korean undiagnosed diseases program phase I: expansion of the nationwide network and the development of long-term infrastructure SCIE SCOPUS

Title
The Korean undiagnosed diseases program phase I: expansion of the nationwide network and the development of long-term infrastructure
Authors
Kim, Soo YeonLee, SeungbokWoo, HyewonHan, JiyeonKo, Young JunShim, YoungkyuPark, SoojinJang, Se SongLim, Byung ChanKo, Jung MinKim, Ki JoongCho, AnnaKim, HunminHwang, HeeChoi, Ji EunKim, Man JinMoon, JangsupSeong, Moon-WooPark, Sung SupChoi, Sun AhLee, Ji EunKwon, Young SeSohn, Young BaeKim, Jon SooKim, Won SeopLee, Yun JeongKwon, SoonhakKim, Young OkKook, HoonCho, Yong GonCheon, Chong KunKang, Ki-SooSong, Mi-RyoungKim, Young-JoonCha, Hyuk-JinChoi, Hee-JungKee, YunPark, Sung-GyooBaek, Seung TaeChoi, MurimRyu, Dong-SungChae, Jong-Hee
Date Issued
2022-10
Publisher
BMC
Abstract
Background Phase I of the Korean Undiagnosed Diseases Program (KUDP), performed for 3 years, has been completed. The Phase I program aimed to solve the problem of undiagnosed patients throughout the country and develop infrastructure, including a data management system and functional core laboratory, for long-term translational research. Herein, we share the clinical experiences of the Phase I program and introduce the activities of the functional core laboratory and data management system. Results During the program (2018-2020), 458 patients were enrolled and classified into 3 groups according to the following criteria: (I) those with a specific clinical assessment which can be verified by direct testing (32 patients); (II) those with a disease group with genetic and phenotypic heterogeneity (353 patients); and (III) those with atypical presentations or diseases unknown to date (73 patients). All patients underwent individualized diagnostic processes based on the decision of an expert consortium. Confirmative diagnoses were obtained for 242 patients (52.8%). The diagnostic yield was different for each group: 81.3% for Group I, 53.3% for Group II, and 38.4% for Group III. Diagnoses were made by next-generation sequencing for 204 patients (84.3%) and other genetic testing for 35 patients (14.5%). Three patients (1.2%) were diagnosed with nongenetic disorders. The KUDP functional core laboratory, with a group of experts, organized a streamlined research pipeline covering various resources, including animal models, stem cells, structural modeling and metabolic and biochemical approaches. Regular data review was performed to screen for candidate genes among undiagnosed patients, and six different genes were identified for functional research. We also developed a web-based database system that supports clinical cohort management and provides a matchmaker exchange protocol based on a matchbox, likely to reinforce the nationwide clinical network and further international collaboration. Conclusions The KUDP evaluated the unmet needs of undiagnosed patients and established infrastructure for a data-sharing system and future functional research. The advancement of the KUDP may lead to sustainable bench-to-bedside research in Korea and contribute to ongoing international collaboration.
URI
https://oasis.postech.ac.kr/handle/2014.oak/114509
DOI
10.1186/s13023-022-02520-5
ISSN
1750-1172
Article Type
Article
Citation
ORPHANET JOURNAL OF RARE DISEASES, vol. 17, no. 1, 2022-10
Files in This Item:
There are no files associated with this item.

qr_code

  • mendeley

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher

백승태BAEK, SEUNG TAE
Dept of Life Sciences
Read more

Views & Downloads

Browse